Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for “live high-train low” effectiveness
Crossref DOI link: https://doi.org/10.1007/s00421-017-3664-3
Published Online: 2017-06-29
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brocherie, Franck https://orcid.org/0000-0002-0808-7986
Schmitt, L.
Millet, G. P.
License valid from 2017-06-29
